Abstract
About 15 % of all couples experience infertility at some time during their reproductive lives. Nowadays, infertility can be treated by the use of assisted reproductive technologies (ART), such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). A common element of these programs is the treatment with follicle-stimulating hormone (FSH) to increase the number of oocytes retrievable for the IVF or ICSI procedure (multifollicular development). Patients suffering from female infertility because of chronic anovulation may also be treated with FSH, then with the aim to achieve monofollicular development.
Cite
CITATION STYLE
Sam, T., de Leeuw, R., Verheijden, G., & Koole, A. (2013). Follicle-stimulating hormone. In Pharmaceutical Biotechnology: Fundamentals and Applications, Fourth Edition (pp. 277–283). Springer New York. https://doi.org/10.1007/978-1-4614-6486-0_13
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
